loader
Please Wait
Applying Filters...
Close
4

Seqens Seqens

X

List of Tox21_300537 NDC API suppliers/manufacturers & exporters

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 DARMERICA, LLC (1)

02 INDENA SPA (1)

filter

01 RESERPINE (1)

02 Reserpine (1)

filter

01 Italy (1)

02 U.S.A (1)

URL Supplier Web Content
Reserpine
POWDER (10g/10g)
BULK INGREDIENT
71052-422
2020-11-25
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
RESERPINE
POWDER (1g/g)
BULK INGREDIENT
17359-1000
2019-05-14
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 50-55-5 / Reserpine API manufacturers, exporters & distributors?

Reserpine manufacturers, exporters & distributors 1

95

PharmaCompass offers a list of Reserpine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Reserpine manufacturer or Reserpine supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Reserpine manufacturer or Reserpine supplier.

PharmaCompass also assists you with knowing the Reserpine API Price utilized in the formulation of products. Reserpine API Price is not always fixed or binding as the Reserpine Price is obtained through a variety of data sources. The Reserpine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Reserpine

Synonyms

50-55-5, Serpalan, Serpasil, Apoplon, Serpivite, Hypersil

Cas Number

50-55-5

Unique Ingredient Identifier (UNII)

8B1QWR724A

About Reserpine

An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use.

Tox21_300537 Manufacturers

A Tox21_300537 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tox21_300537, including repackagers and relabelers. The FDA regulates Tox21_300537 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tox21_300537 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Tox21_300537 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Tox21_300537 Suppliers

A Tox21_300537 supplier is an individual or a company that provides Tox21_300537 active pharmaceutical ingredient (API) or Tox21_300537 finished formulations upon request. The Tox21_300537 suppliers may include Tox21_300537 API manufacturers, exporters, distributors and traders.

click here to find a list of Tox21_300537 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Tox21_300537 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tox21_300537 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Tox21_300537 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Tox21_300537 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Tox21_300537 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tox21_300537 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Tox21_300537 suppliers with NDC on PharmaCompass.

Tox21_300537 Manufacturers | Traders | Suppliers

Tox21_300537 Manufacturers, Traders, Suppliers 1
40

We have 2 companies offering Tox21_300537

Get in contact with the supplier of your choice:

  1. Darmerica
  2. Indena
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY